0 Books / subject COVID-19
- Administrative Sciences
- Biochemistry, Medicine & Health
- Computer & Communication Sciences
- Environmental Sciences
- Life & Behavioural Sciences
- Rehabilitation & Assistive Technology
- Social Sciences: Economics/Policy/Management
- Townplanning & Architecture
- Transportation Sciences
February 26, 2021 - Amsterdam – COVID-19 has wrought havoc on the global economy and the world’s public health systems. People with disabilities are more likely to suffer severe cases of the disease. Experts advocate in this special issue of the Journal of Vocational Rehabilitation that vocational rehabilitation across the major life phases of health, work, and education must focus on access to technology and home-based employment and ensure people with disabilities are prepared for the new global workplace.
Psychological Distress of Lockdown in Pre-Dementia Patients Prolonged During the COVID-19 De-Escalation
February 3, 2021 - Barcelona, Spain – The effects of the lockdown decreed to deal with the COVID-19 pandemic on the mental health of elderly people in pre-dementia stages were protracted during the de-escalation phase. This is highlighted by an open access study published in the Journal of Alzheimer's Disease, led by researchers from the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar, as well as researchers from the CIBER on the Physiopathology of Obesity and Nutrition (CIBEROBN) and the CIBER on Fragility and Healthy Ageing (CIBERFES). The work was carried out in collaboration with the Barcelona βeta Brain Research Center (BBRC).
February 3, 2021 - Amsterdam, NL – Patients with Parkinson’s disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine’s efficacy and safety in the specific context of PD and its symptomatic treatment. In a commentary just published in the Journal of Parkinson’s Disease, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with PD, unless there is a specific contraindication.
January 4, 2021 - Amsterdam, NL – The impact of the COVID-19 pandemic on children with disabilities has not received much attention, perhaps because the disease disproportionately affects older individuals. In this special issue of the Journal of Pediatric Rehabilitation Medicine experts assess the impact of the pandemic on pediatric patients with special needs, their caregivers, and healthcare providers. They also focus on the growing importance of telemedicine and provide insights and recommendations for mitigating the impact of the virus in the short and long term.
December 10, 2020 - Athens and Patras, Greece – Caregivers of people with dementia and milder forms of neurocognitive disorder bear a heavy burden. They are constantly confronted with challenging symptoms and behaviors and feel they are up against their limits. The latest results from a study published in the Journal of Alzheimer's Disease indicate that the COVID-19 crisis affects this burden since the pandemic has mental health implications.
December 9, 2020 - Amsterdam, NL – WORK: A Journal of Prevention, Assessment & Rehabilitation, published by IOS Press, is committed to helping organizations manage the challenges they face during the COVID-19 pandemic by publishing robust, evidence-based research and commentary. All articles featured here and in the WORK COVID-19 Collection are freely available.
December 8, 2020 - Amsterdam, NL – The COVID-19 pandemic has disrupted all types of organizations, leading human resources managers to reconsider their roles to support the implementation of social distancing practices, safety measures, and new ways of working. A special issue of Human Systems Management looks at the behavioral challenges posed by new ways of working and presents new models and tools to help organizations manage the transition.
September 22, 2020 - Mebourne, Australia – Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health. A team of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve.
September 21, 2020 - Tokyo, Japan – The ongoing coronavirus disease 2019 (COVID-19) pandemic has substantially affected patients with dementia and their caregivers. Owing to the restrictive measures taken worldwide to block the spread of COVID-19 outbreaks (including the declaration of a state of emergency in Japan), patients with dementia and their caregivers have not been able to receive the usual support and care. Therefore, this is expected to lead to adverse effects on the patients and their caregivers, and many investigators have warned about the risks [1–3]. In fact, many scheduled appointments for routine outpatients’ examinations and care services have been canceled and postponed owing to the COVID-19 outbreak.
July 6, 2020 - Due to the spread of the coronavirus (COVID-19) gradually decreasing, the Dutch government is slowly easing its regulations, effective from July 1, 2020.
June 29, 2020 - Amsterdam NL – The SARS-CoV-19 virus initially has a limited capability to invade, attacking only one intracellular genetic target, the aryl hydrocarbon receptors (AhRs). Yet it leads to widely diverse clinical symptoms, suggesting multiple pathogenic mechanisms. Writing in Restorative Neurology and Neuroscience, investigators describe how excessive activation of AhRs via the IDO1-kynurenine-AhR signaling pathway, which is used by many pathogens to establish infection, leads to “Systemic AhR Activation Syndrome” (SAAS). The authors also hypothesize that therapies targeting downregulation of AhRs and IDO1 genes should decrease severity of infection.
May 12, 2020 - Amsterdam, NL – Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD. Writing in the Journal of Parkinson's Disease (JPD), scientists discuss several avenues through which the COVID-19 pandemic might contribute to the expected exponential growth of PD in the coming years, compounding the economic and societal impacts of the disease.
Passive Immunization May Slow Down SARS-CoV-2 and Boost Immunity in Patients, Buying Time Until Vaccines Are Developed
May 12, 2020 - Amsterdam, NL – The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority. However, creating a viable vaccine might take a long time; scientists estimate a vaccine may be available in between 12 and 18 months. A potential interim solution reported in the International Journal of Risk & Safety in Medicine may be a passive vaccine, or passive immummization (PI), which can provide instant, short-term fortification against infectious agents.
May 1, 2020 - Ancona, Italy – COVID-19 disease is characterized by serious clinical manifestations which could require urgent hospitalization. Prolonged hospitalization, with catabolism and immobilization, induces a decrease in weight and muscle mass which can result in sarcopenia, a condition that impairs respiratory and cardiac function, worsening the prognosis.
April 3, 2020 - Amsterdam, NL – While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson’s disease (PD), the impact extends beyond these threats. Social distancing requires flexible adaptation to new circumstances, resilience, and a reduction in physical activities, which may be more difficult for patients with PD.